Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and coronary artery disease (CAD) is the cardiac manifestation of metabolic syndrome. NAFLD is strongly linked to CAD and hepatic steatosis is an independent risk factor for CAD and cardiac morta...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Open Gastroenterol
Prif Awduron: Mehta, Rohini, Otgonsuren, Munkzhul, Younoszai, Zahra, Allawi, Hussain, Raybuck, Bryan, Younossi, Zobair
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2016
Pynciau:
Hepatology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964159/
https://ncbi.nlm.nih.gov/pubmed/27493762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2016-000096
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg